CDC protects and prepares communities [Korean]
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

CDC protects and prepares communities [Korean]

Filetype[PDF-835.13 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Filetype[PDF - 65.84 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical manage...
      File Type:
      Filetype[PDF - 65.84 KB]
      File Type:
      Filetype[PDF - 65.84 KB]
    2. Filetype[PDF - 517.96 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Updated March 20, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is...
      File Type:
      Filetype[PDF - 517.96 KB]
      File Type:
      Filetype[PDF - 517.96 KB]
    3. Filetype[PDF - 542.80 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea...
      File Type:
      Filetype[PDF - 542.80 KB]
      File Type:
      Filetype[PDF - 542.80 KB]
    4. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 539.17 KB]
      File Type:
      Filetype[PDF - 539.17 KB]
    5. Filetype[PDF - 832.93 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      18//03/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Vietnamese]CDC Ä‘ang quyêÌt liệt Æ°Ìng phoÌ vÆ¡Ìi sÆ°Ì£ buÌ€ng phaÌt toaÌ€n cầu của COVID-19 vaÌ...
      File Type:
      Filetype[PDF - 832.93 KB]
      File Type:
      Filetype[PDF - 832.93 KB]
    6. Filetype[PDF - 822.75 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Spanish]Los CDC estaÌn respondiendo eneÌrgicamente al brote mundial de COVID-19 y su propagacioÌn comunitari...
      File Type:
      Filetype[PDF - 822.75 KB]
      File Type:
      Filetype[PDF - 822.75 KB]
    7. Filetype[PDF - 884.64 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Chinese]CDC正在积æžåº”对全çƒCOVID-19的爆å‘以åŠç¾Žå›½å¢ƒå†…的社区传播。cdc.gov/COVID19CS 31545...
      File Type:
      Filetype[PDF - 884.64 KB]
      File Type:
      Filetype[PDF - 884.64 KB]
    8. Filetype[PDF - 224.26 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 224.26 KB]
      File Type:
      Filetype[PDF - 224.26 KB]
    9. Filetype[PDF - 813.54 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S.cdc.gov/COVID19CS 315454-Ainfographic-cdc-protects-5...
      File Type:
      Filetype[PDF - 813.54 KB]
      File Type:
      Filetype[PDF - 813.54 KB]
    10. Filetype[PDF - 216.07 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 22, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 216.07 KB]
      File Type:
      Filetype[PDF - 216.07 KB]
    11. Filetype[PDF - 346.12 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda...
      File Type:
      Filetype[PDF - 346.12 KB]
      File Type:
      Filetype[PDF - 346.12 KB]
    12. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea...
      File Type:
      Filetype[PDF - 539.17 KB]
      File Type:
      Filetype[PDF - 539.17 KB]
    13. Filetype[PDF - 170.47 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ; SRC, Inc. ;
      Published Date:
      February 2020
      Series:
      ToxFAQs
      Description:
      2-Hexanone is also known as methyl n-butyl ketone, MBK, or propyl acetone. It is a clear, colorless liquid with a sharp odor. It dissolves very easily...
      File Type:
      Filetype[PDF - 170.47 KB]
      File Type:
      Filetype[PDF - 170.47 KB]
    14. Filetype[PDF - 178.71 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ; SRC, Inc. ;
      Published Date:
      Septiembre 1995
      Series:
      ToxFAQs
      Description:
      2-Hexanone - ToxFAQs [Spanish]La 2-hexanona se conoce también como metil n-butil cetona (MBK) o propil acetona. Es un líquido incoloro de aroma pene...
      File Type:
      Filetype[PDF - 178.71 KB]
      File Type:
      Filetype[PDF - 178.71 KB]

You May Also Like:

  1. Filetype[PDF - 597.12 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 16, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated July 16, 2021
    File Type:
    Filetype[PDF - 597.12 KB]
    File Type:
    Filetype[PDF - 597.12 KB]
  2. Filetype[PDF - 331.78 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Mar 17, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Mar. 17, 2021
    File Type:
    Filetype[PDF - 331.78 KB]
    File Type:
    Filetype[PDF - 331.78 KB]
  3. Filetype[PDF - 187.23 KB]
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Diabetes Translation.
    Published Date:
    Feb. 10, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Feb. 10, 2021This interim guidance has been updated based on currently available information about COVID-19 and the current situation in the U...
    File Type:
    Filetype[PDF - 187.23 KB]
    File Type:
    Filetype[PDF - 187.23 KB]
  4. Filetype[PDF - 321.97 KB]
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Diabetes Translation.
    Published Date:
    April 3, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Audience: These considerations are intended for use by federal, state, and local public health officials, respiratory protection program managers, lea...
    File Type:
    Filetype[PDF - 321.97 KB]
    File Type:
    Filetype[PDF - 321.97 KB]
  5. Filetype[PDF - 2.57 MB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 9, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated July 9, 2021
    File Type:
    Filetype[PDF - 2.57 MB]
    File Type:
    Filetype[PDF - 2.57 MB]